MedTrace Logo

Use of Axillary Ultrasound to Guide Breast Cancer Management in the Genomic Assay Era

NCT06038110 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2023-09-14

No results posted yet for this study

Summary

The investigators aimed to determine if axillary ultrasound can reliably distinguish between patients with limited or high nodal burden, so that the patients with limited nodal burden can potentially avoid chemotherapy and instead receive upfront surgery followed by gene assay testing.

Conditions

  • Axillary Ultrasound

Interventions

DIAGNOSTIC_TEST

axillary ultrasound

usefulness of axillary ultrasound in predicting need for chemotherapy or upfront surgery

Sponsors & Collaborators

  • KK Women's and Children's Hospital

    lead OTHER_GOV

Eligibility

Min Age
21 Years
Max Age
100 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-01
Primary Completion
2024-01-31
Completion
2024-01-31

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06038110 on ClinicalTrials.gov